Malignant ventricular tachyarrhythmias associated with the use of encainide
Authors:
- Roger A WinkleRWRoger A Winkle
- 1 November 1981
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 102 (5) , 857-864
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clinical pharmacology and antiarrhythmic efficacy of encainide in patients with chronic ventricular arrhythmias.Circulation, 1981
- Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia.Circulation, 1981
- Total Suppression of Ventricular Arrhythmias by EncainideNew England Journal of Medicine, 1980
- Clinical electrophysiologic effects of encainide, a newly developed antiarrhythmic agentThe American Journal of Cardiology, 1979
- Canine electrophysiology of encainide, a new antiarrhythmic drugThe American Journal of Cardiology, 1979
- Electrophysiological Actions of Lorcainide in Patients with Cardiac DiseaseJournal of Cardiovascular Pharmacology, 1979
- Atypical ventricular tachycardia as a manifestation of disopyramide toxicityThe American Journal of Cardiology, 1978
- Electrophysiologic effects of encainide (MJ 9067) on canine purkinje fibresEuropean Journal of Pharmacology, 1978
- Quinidine SyncopeCirculation, 1964